Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families.
(00:32)
Would each of you share a little bit about yourselves and your background? Dr. Shen?
(01:25)
Rihanna, could we have you give a little background about yourself as well?
(01:48)
Could you provide us with an overview of Lynch syndrome?
(03:44)
Can you expand on why genetic testing for Lynch syndrome is so important?
(06:03)
Who would benefit from Lynch testing?
(07:51)
Is Lynch syndrome the only type of inherited predisposition to colon cancer?
(08:48)
Does the healthcare provider order these tests, and what kind of samples should be considered in these patients?
(10:50)
Are there any limitations to the types of variants that can be detected by this test? And how does Mayo Clinic Laboratories ensure comprehensive results for patients?
(14:24)
How are the results used in patient care?
(16:33)
Could you summarize the benefits of these tests and of doing them at Mayo Clinic Laboratories?